Platelets and hypersensitivity.

J R de Sousa; A G Palma-Carlos

PubMed · 7551199

Platelets and hypersensitivity.

Abstract

Platelets are anucleated blood cells not exclusively committed to hemostasis. They participate in inflammation, tissue repair, the immune response and hypersensitivity. In this review, the role of platelets in hypersensitivity is summarized. In order to understand the profound implications of these cells, the authors introduce the involvement of platelets in inflammation and immune reactions. Both the pathophysiology and the biology of the interaction of platelets with other cells are then summarized. These interactions justify the actual knowledge about the possibilities for the involvement of platelets in clinical states of hypersensitivity. Furthermore, the participation of platelets in allergy is supported by biological and clinical evidence, including in vitro studies of platelet activity in hypersensitivity states, the demonstration of platelet killing and the response to parasite contact, as well as animal studies in which the response to immune aggression is dependent on platelet reactivity. However, the need for more complete and developed clinical studies is clearly stressed, as several therapeutic approaches can already be proposed for a better control of these processes.

Explore related subjects

Blood Platelets Humans Hypersensitivity Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J R de Sousa, A G Palma-Carlos. Platelets and hypersensitivity.. https://pubmed.ncbi.nlm.nih.gov/7551199/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Dynamic lysine acetylation and succinylation of platelet proteins regulates platelet storage lesion: mechanistic insights from multi-omics.

OBJECTIVES: Platelet storage lesion (PSL) severely impairs platelet function during storage, presenting a major hurdle in transfusion medicine; however, the dynamic interplay between global proteomic changes and post-translational modifications (PTMs) underlying these functional deteriorations remains insufficiently characterized. Here, we report the first comprehensive multi-omics analysis integrating global proteomics, acetylomics, and succinylomics to dissect the molecular dynamics during platelet storage. METHODS: We performed quantification of global proteomics, acetylome and succinylome based on TMT-labeled LC-MS/MS analysis, combined with antibody-affinity enrichment and purification. Dynamic molecular changes and functional transformation of platelet were also characterized under proper conditions stored for 1, 3, 5, 7 days, respectively. RESULTS: We systematically characterized 3,609 proteins, 1,308 acetylation sites, and 1,947 succinylation sites across multiple storage time points (D1, D3, D5, D7). We distinct temporal patterns of post-translational modifications, with succinylation showing more extensive coverage than acetylation in platelets. Pathway enrichment analysis revealed extensive metabolic reprogramming involving complement activation, energy metabolism, and cellular detoxification processes. The identification of specific motif patterns provided mechanistic insights into the functional specificity of these modifications. Random forest machine learning identified 20 core regulatory proteins representing critical nodes in PSL development. Furthermore, we employed real - time quantitative polymerase chain reaction (RT - QPCR) to measure the expression levels of key genes related to platelet function and PTM - associated pathways. CONCLUSION: By mapping the interplay between proteomic abundance shifts and PTM dynamics, this study provides a multidimensional understanding of PSL, establishing a foundational framework for optimizing storage protocols and enhancing transfusion safety.

Blood Platelets↗

PubMed2001

Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion.

Explore the source record for details and available documents.

Blood Platelets↗

PubMed2001

Thrombopoietin stimulates cortactin translocation to the cytoskeleton independently of tyrosine phosphorylation.

Cortactin is an F-actin-binding protein expressed in platelets. During aggregation by thrombin, cortactin associates with Src, is tyrosine phosphorylated, and then translocates to the cytoskeleton. It is also found to associate with Syk during platelet shape change. Since cortactin undergoes tyrosine phosphorylation in platelets activated by thrombopoietin (TPO) that exhibit neither shape change nor aggregation, we investigated whether it could also relocalize to the detergent-insoluble fraction. We demonstrate that cortactin was present as a tyrosine-phosphorylated protein and co-localized with Syk in the Triton X-100-insoluble fraction of TPO-activated platelets. TPO stimulated Syk activation and association with cortactin. Conversely, cortactin associated with the kinases, Syk and Src. Cortactin tyrosine phosphorylation was blocked by Syk kinase inhibitor, piceatannol or Src family kinase inhibitor, PP2, suggesting that it depends on these two kinases. However, piceatannol or PP2 did not prevent cortactin translocation to the detergent-insoluble fraction. These data suggest that tyrosine phosphorylation is not required for cortactin translocation to the detergent-insoluble compartment. Furthermore, TPO activates, through its receptor c-Mpl, a signalling pathway to the cytoskeleton.

Blood Platelets↗